BTK and Bruton-type agammaglobulinemia: Bruton’s tyrosine kinase (BTK), a member of the TEC kinase family, was originally identified as a non-receptor protein tyrosine kinase that is mutated and defective in patients with X−linked agammaglobulinemia (XLA) (1–3).